POLICY · REGULATION · #575
AI labs' call for a 'slowdown' raises antitrust concerns
Leading AI companies have publicly discussed a coordinated ‘slowdown’ in AI development to address safety risks; antitrust experts warn that language about collectively pausing or reducing development could be interpreted as an illegal agreement to limit competition under U.S. law. Commentators suggest safer framings—emphasizing joint safety standards or using legal mechanisms like the National Cooperative Research and Production Act or ancillary‑restraints doctrine—to reduce legal exposure.
KEY POINTS
- Leading AI companies have publicly discussed a coordinated ‘slowdown’ in AI development to address safety risks; antitrust experts warn that language about collectively pausing or reducing development could be interpreted as an illegal agreement to limit competition under U.S.
- Commentators suggest safer framings—emphasizing joint safety standards or using legal mechanisms like the National Cooperative Research and Production Act or ancillary‑restraints doctrine—to reduce legal exposure.
- How AI companies describe and coordinate safety measures could trigger antitrust enforcement, shaping what forms of collective safety action are legally feasible.
WHY IT MATTERS
How AI companies describe and coordinate safety measures could trigger antitrust enforcement, shaping what forms of collective safety action are legally feasible.